| Literature DB >> 35832684 |
Emily E Karp1, Jamie J Van Gompel1,2, Garret Choby1,2.
Abstract
Esthesioneuroblastoma is a rare malignancy originating from the olfactory epithelium. Treatment consists of surgical resection with strong consideration for adjuvant treatment in advanced Kadish stage and high Hyams grade. In the modern era, overall outcomes for esthesioneuroblastoma are favorable compared with many other sinonasal malignancies with 5-year overall survival estimated to be 80%. When selecting the optimal surgical approach, the surgeon must consider the approach that will allow for a negative margin resection and adequate reconstruction. In appropriately selected patients, endoscopic outcomes appear at least equivalent to open approaches and unilateral endoscopic approach may be used in select olfactory preservation cases. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ).Entities:
Keywords: craniofacial resection; endoscopic; esthesioneuroblastoma; neuroblastoma; olfactory
Year: 2022 PMID: 35832684 PMCID: PMC9272014 DOI: 10.1055/s-0042-1753519
Source DB: PubMed Journal: J Neurol Surg Rep ISSN: 2193-6358
Fig. 1( A ) Case presentation of coronal magnetic resonance imaging, T1 postgadolinium. ( B ) Arrow indicates contralateral olfactory tract involvement.
Fig. 2Endoscopic bilateral craniofacial resection.